Coronary heart disease and myocardial infarction (MI) are regarded a major public health concern around the world. In the United States, the number of patients who have coronary artery disease has increased noticeably. According to the American Heart Association (AHA), roughly one in every seven deaths in the United States occurred in 2018. According to the survey, adults with cardiac infection account for almost 7.9 million (3 percent) people. As a result, demand for peptide and anticoagulant drugs market has increased dramatically.
Frequently Asked Questions
The market is segmented based on Global Peptide and Anticoagulant Drugs Market Segmentation, By Low Molecular Weight Heparin Type (Heparin Sodium, Enoxaparin Sodium, Dalteparin Sodium, and Fondaparinux), Type (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, Others), Indication (Diabetes, Infectious Diseases, Cancer, Osteoporosis, Cardiology, Gynecology, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Peptide And Anticoagulant Drugs Market size was valued at USD 1.83 USD Billion in 2024.
The Global Peptide And Anticoagulant Drugs Market is projected to grow at a CAGR of 6.1% during the forecast period of 2025 to 2032.
The major players operating in the market include F. Hoffmann-La Roche Ltd. , Mylan N.V. , Teva Pharmaceutical Industries Ltd. , Sanofi , Pfizer Inc. , GlaxoSmithKline plc , Novartis AG , Merck &, Co.Inc. , Allergan , AstraZeneca , Johnson &, Johnson Private Limited , Hikma Pharmaceuticals PLC , Fresenius Kabi AG , Eisai Co.Ltd. ,Bristol-Myers Squibb Company , Bayer AG , DAIICHI SANKYO COMPANY, LIMITED , Boehringer Ingelheim International GmbH. , Dr. Reddy',s Laboratories Ltd. , Aspen Holdings .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
